Pancreatic cancer has been notoriously difficult to treat effectively, leading to it being one of the deadliest cancers. A drug in Phase 3 called daraxonrasib has shown promising data that suggest a doubling of extension of life compared to standard chemotherapy.
getty
Data presented at last…
Leave a Reply